Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 575, doi. 10.1038/onc.2008.405
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 4
Results: 15
1
2
Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 500, doi. 10.1038/onc.2008.406
- By:
- Publication type:
- Article
3
PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 509, doi. 10.1038/onc.2008.407
- By:
- Publication type:
- Article
4
Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin–proteasome pathway.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 492, doi. 10.1038/onc.2008.403
- By:
- Publication type:
- Article
5
Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 565, doi. 10.1038/onc.2008.404
- By:
- Publication type:
- Article
6
Increased nucleotide polymorphic changes in the 5′-untranslated region of δ-catenin (CTNND2) gene in prostate cancer.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 555, doi. 10.1038/onc.2008.399
- By:
- Publication type:
- Article
7
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 619, doi. 10.1038/onc.2008.401
- By:
- Publication type:
- Article
8
Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 479, doi. 10.1038/onc.2008.402
- By:
- Publication type:
- Article
9
Palladin contributes to invasive motility in human breast cancer cells.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 587, doi. 10.1038/onc.2008.408
- By:
- Publication type:
- Article
10
New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 545, doi. 10.1038/onc.2008.409
- By:
- Publication type:
- Article
11
The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 534, doi. 10.1038/onc.2008.410
- By:
- Publication type:
- Article
12
Disruption of the EGFR E884–R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 518, doi. 10.1038/onc.2008.411
- By:
- Publication type:
- Article
13
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 599, doi. 10.1038/onc.2008.414
- By:
- Publication type:
- Article
14
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 469, doi. 10.1038/onc.2008.415
- By:
- Publication type:
- Article
15
Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay.
- Published in:
- Oncogene, 2009, v. 28, n. 4, p. 610, doi. 10.1038/onc.2008.424
- By:
- Publication type:
- Article